Alpha Teknova Inc.

NASDAQ: TKNO · Real-Time Price · USD
6.60
0.09 (1.38%)
At close: May 16, 2025, 3:59 PM
6.62
0.23%
After-hours: May 16, 2025, 04:05 PM EDT

Alpha Teknova Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Clinical Solutions Revenue 7.1M 6.74M 8.45M 6.79M
Clinical Solutions Revenue Growth +5.33% -20.21% +24.32% n/a
Lab Essentials Revenue 28.88M 28.8M 31.77M 27.18M
Lab Essentials Revenue Growth +0.29% -9.35% +16.88% n/a
Other Product Revenue 1.76M 1.15M 1.2M 1.39M
Other Product Revenue Growth +54.01% -4.26% -13.64% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 7.13M 6.88M 6.61M 6.94M 7.75M 8.43M 8.55M 8.12M 9.69M 10M 8.9M 9.66M 8.89M 8.07M 6.49M 4.74M 4.87M 4M 2.29M 2.14M 2M
Selling, General, and Administrative Revenue Growth +3.74% +4.04% -4.77% -10.44% -8.04% -1.46% +5.33% -16.22% -3.13% +12.38% -7.85% +8.60% +10.20% +24.29% +36.90% -2.55% +21.50% +74.81% +7.21% +6.64% n/a
Research and Development Revenue 552K 594K 627K 678K 860K 1.31M 1.4M 1.46M 1.4M 1.87M 1.93M 1.93M 2.01M 1.39M 1.37M 851K 700K 482K 358K 341K 326K
Research and Development Revenue Growth -7.07% -5.26% -7.52% -21.16% -34.40% -6.16% -4.58% +4.95% -25.40% -2.86% -0.21% -4.17% +44.82% +1.31% +61.22% +21.57% +45.23% +34.64% +4.99% +4.60% n/a
Sales and Marketing Revenue 1.64M 1.56M 1.64M 1.46M 1.67M 2.4M 2.41M 2.17M 2.34M 2.56M 2.4M 2.6M 1.6M 1.28M 885K 904K 705K 840K 558K 481K 349K
Sales and Marketing Revenue Growth +5.33% -5.06% +12.64% -12.66% -30.57% -0.46% +10.95% -7.21% -8.44% +6.76% -7.74% +62.68% +24.47% +44.97% -2.10% +28.23% -16.07% +50.54% +16.01% +37.82% n/a